Dysregulation in Multiple Transcriptomic Endometrial Pathways Is Associated with Recurrent Implantation Failure and Recurrent Early Pregnancy Loss.

differentially expressed genes (DEGs) endometrial biopsy endometrial pathways gene expression profile recurrent early pregnancy loss (REPL) recurrent implantation failure (RIF)

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
16 Dec 2022
Historique:
received: 13 06 2022
revised: 08 11 2022
accepted: 05 12 2022
entrez: 23 12 2022
pubmed: 24 12 2022
medline: 27 12 2022
Statut: epublish

Résumé

Overlapping disease aetiologies associated with multiple altered biological processes have been identified that change the endometrial function leading to recurrent implantation failure (RIF) and recurrent early pregnancy loss (REPL). We aimed to provide a detailed insight into the nature of the biological malfunction and related pathways of differentially expressed genes in RIF and REPL. Endometrial biopsies were obtained from 9 women experiencing RIF, REPL and control groups. Affymetrix microarray analysis was performed to measure the gene expression level of the endometrial biopsies. Unsupervised clustering of endometrial samples shows scattered distribution of gene expression between the RIF, REPL and control groups. 2556 and 1174 genes (p value < 0.05, Fold change > 1.2) were significantly altered in the endometria of RIF and REPL patients’ group, respectively compared to the control group. Downregulation in Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways of the differentially expressed genes (DEGs) in RIF and REPL including ribosome and oxidative phosphorylation pathways. Gene Ontology (GO) analysis revealed ribosomes and mitochondria inner membrane as the most significantly downregulated cellular component (CC) affected in RIF and REPL. Determination of the dysregulated genes and related biological pathways in RIF and REPL will be key in understanding their molecular pathology and of major importance in addressing diagnosis, prognosis, and treatment issues

Identifiants

pubmed: 36555686
pii: ijms232416051
doi: 10.3390/ijms232416051
pmc: PMC9782216
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : the European Union's Horizon 2020
ID : 668989
Organisme : CellFit COST Action
ID : CA16119
Organisme : the European Union's Horizon 2020 research and innovation programme under grant agreement
ID : 857418
Organisme : Ministry of Education (Higher education Malaysia) and Universiti Teknologi MARA (UiTM), Malaysia
ID : 326671

Références

Fertil Steril. 2004 Nov;82(5):1264-72
pubmed: 15533340
Geburtshilfe Frauenheilkd. 2018 Apr;78(4):364-381
pubmed: 29720743
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
Mol Hum Reprod. 2004 May;10(5):291-7
pubmed: 15026541
PLoS Med. 2012;9(12):e1001356
pubmed: 23271957
Reprod Biomed Online. 2008 Sep;17(3):425-35
pubmed: 18765015
Int J Mol Sci. 2020 Nov 23;21(22):
pubmed: 33238645
Am J Reprod Immunol. 2016 Mar;75(3):388-401
pubmed: 26777262
Reprod Biomed Online. 2014 Jan;28(1):14-38
pubmed: 24269084
Hum Reprod. 2009 Jun;24(6):1436-45
pubmed: 19246470
Clin Chim Acta. 2017 Jan;464:17-23
pubmed: 27836685
Int J Reprod Biomed. 2020 Mar 29;18(3):193-208
pubmed: 32309768
Proteomics Clin Appl. 2016 May;10(5):554-63
pubmed: 26947931
Front Genet. 2018 Nov 15;9:533
pubmed: 30498507
J Transl Med. 2021 Apr 28;19(1):176
pubmed: 33910562
Neuropsychopharmacology. 2018 Oct;43(11):2264-2276
pubmed: 30054583
Protein Cell. 2020 May;11(5):318-338
pubmed: 31919741
Placenta. 2013 Feb;34(2):133-40
pubmed: 23266290
Biol Reprod. 2019 Sep 1;101(3):549-566
pubmed: 31077289
Cell. 2014 Nov 20;159(5):979-984
pubmed: 25416939
J Clin Endocrinol Metab. 2014 Dec;99(12):E2744-53
pubmed: 25243572
Postgrad Med J. 2015 Mar;91(1073):151-62
pubmed: 25681385
PeerJ. 2021 Mar 12;9:e11009
pubmed: 33763303
J Assist Reprod Genet. 1998 Apr;15(4):173-6
pubmed: 9565843
Clin Proteomics. 2021 Feb 22;18(1):9
pubmed: 33618676
Reproduction. 2017 Jun;153(6):749-758
pubmed: 28283674
Fertil Res Pract. 2019 Aug 5;5:9
pubmed: 31396393
Sci Rep. 2016 Dec 08;6:38439
pubmed: 27929073
Trends Mol Med. 2007 Jul;13(7):310-7
pubmed: 17574920
Hum Reprod. 1999 Dec;14 Suppl 2:3-16
pubmed: 10690796
Exp Mol Pathol. 2007 Aug;83(1):84-92
pubmed: 17239370
Sci Rep. 2016 Jan 22;6:19411
pubmed: 26797113
Fertil Steril. 2008 Nov;90(5 Suppl):S60
pubmed: 19007647
PLoS One. 2016 Jun 15;11(6):e0157696
pubmed: 27304912
Reprod Biol Endocrinol. 2018 Dec 5;16(1):121
pubmed: 30518389
Neural Regen Res. 2013 Feb 5;8(4):363-75
pubmed: 25206677
Rev Obstet Gynecol. 2009 Spring;2(2):76-83
pubmed: 19609401
Iran J Reprod Med. 2014 Feb;12(2):131-8
pubmed: 24799871
Reprod Biol. 2012 Jul;12(2):183-99
pubmed: 22850470
J Assist Reprod Genet. 2012 Nov;29(11):1227-39
pubmed: 22976427
Reprod Sci. 2019 Jul;26(7):879-890
pubmed: 30081718
N Engl J Med. 1999 Jun 10;340(23):1796-9
pubmed: 10362823
Semin Reprod Med. 2007 Nov;25(6):454-60
pubmed: 17960530

Auteurs

Norhayati Liaqat Ali Khan (N)

Academic Unit of Reproductive and Developmental Medicine, Department of Oncology and Metabolism, The Medical School, University of Sheffield, Sheffield S10 2HQ, UK.
Faculty of Dentistry, Universiti Teknologi MARA (UiTM), Sungai Buloh 47000, Malaysia.

Tamer Nafee (T)

Academic Unit of Reproductive and Developmental Medicine, Department of Oncology and Metabolism, The Medical School, University of Sheffield, Sheffield S10 2HQ, UK.

Tingting Shao (T)

Academic Unit of Reproductive and Developmental Medicine, Department of Oncology and Metabolism, The Medical School, University of Sheffield, Sheffield S10 2HQ, UK.

Amber Rose Hart (AR)

Academic Unit of Reproductive and Developmental Medicine, Department of Oncology and Metabolism, The Medical School, University of Sheffield, Sheffield S10 2HQ, UK.

Sarah Elliott (S)

Academic Unit of Reproductive and Developmental Medicine, Department of Oncology and Metabolism, The Medical School, University of Sheffield, Sheffield S10 2HQ, UK.

Bolarinde Ola (B)

Sheffield Teaching Hospitals NHS Foundation Trust, University of Sheffield, Sheffield S10 2HQ, UK.

Paul Roy Heath (PR)

Sheffield Institute for Translational Neuroscience (SITRAN), University of Sheffield, Sheffield S10 2HQ, UK.

Alireza Fazeli (A)

Academic Unit of Reproductive and Developmental Medicine, Department of Oncology and Metabolism, The Medical School, University of Sheffield, Sheffield S10 2HQ, UK.
Department of Pathophysiology, Institute of Biomedicine and Translational Medicine, Faculty of Medicine, University of Tartu, 14B Ravila, 50411 Tartu, Estonia.
Institute of Veterinary Medicine and Animal Sciences, Estonian University of Life Sciences, 51014 Tartu, Estonia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH